Extrahepatic manifestations associated with hepatitis C virus infection - A prospective multicenter study of 321 patients

被引:423
作者
Cacoub, P
Renou, C
Rosenthal, E
Cohen, P
Loury, I
Loustaud-Ratti, V
Yamamoto, AM
Camproux, AC
Hausfater, P
Musset, L
Veyssier, P
Raguin, G
Piette, JC
机构
[1] Hop La Pitie Salpetriere, Dept Internal Med, F-75651 Paris 13, France
[2] Hop La Pitie Salpetriere, Immunochem Lab, F-75651 Paris 13, France
[3] Fac Med Necker Enfants Malad, Immunol Lab, Paris, France
[4] Hop La Croix St Simon, Dept Internal Med, Paris, France
[5] Hop Hyeres, Dept Internal Med, Hyeres, France
[6] Hop Archet, Dept Internal Med, Nice, France
[7] Hop Avicenne, Dept Internal Med, F-93009 Bobigny, France
[8] Hop St Andre, Dept Internal Med, Bordeaux, France
[9] Hop Limoges, Dept Internal Med, Limoges, France
[10] Hop Compiegne, Dept Internal Med, Compiegne, France
关键词
D O I
10.1097/00005792-200001000-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
From January 1996 to January 1997, 321 patients with an average age of 46 ± 16 years and chronically infected with hepatitis C virus (HCV) were prospectively enrolled in a study designed to determine the prevalence of extrahepatic manifestations associated with HCV infection in a large cohort of HCV patients, to identify associations between clinical and biologic manifestations, and to compare the results obtained in human immunodeficiency virus (HIV) positive versus HIV-negative subsets. In a cross-sectional study, clinical extrahepatic manifestations, viral coinfections with HIV and/or hepatitis B virus, connective tissue diseases, and a wide panel of autoantibodies were assessed. Thirty-eight percent (122/321) of patients presented at least 1 clinical extrahepatic manifestation including arthralgia (60/321, 19%), skin manifestations (55/321, 17%), xerostomia (40/321, 12%), xerophthalmia (32/321, 10%), and sensory neuropathy (28/321, 9%). Main biologic abnormalities were mixed cryoglobulins (110/196, 56%), thrombocytopenia (50/291, 17%), and the presence of the following autoantibodies: antinuclear (123/302, 41%), rheumatoid factor (107/280, 38%), anticardiolipin (79/298, 27%), antithyroglobulin (36/287, 13%) and antismooth muscle cell (27/288, 9%). At least 1 autoantibody was present in 210/302 (70%) of sera. By multivariate logistic regression analysis, 4 parameters were significantly associated with cryoglobulin positivity: systemic vasculitis (p = 0.01, odds ratio [OR] = 17.3), HIV positivity (p = 0.0006, OR = 10.2), rheumatoid factor positivity (p = 0.01, OR = 2.8), and sicca syndrome (p = 0.03, OR = 0.27). A definite connective tissue disease was noted in 44 patients (14%), mainly symptomatic mixed cryoglobulinemia and systemic vasculitis. HIV coinfection (23%) was associated with 3 parameters: anticardiolipin (p = 0.003, OR = 4.18), thrombocytopenia (p = 0.01, OR = 3.56), and arthralgia or myalgia (p = 0.017, OR = 0.23). HIV-positive patients presented more severe histologic lesions (p = 0.0004). Extrahepatic clinical manifestations in HCV patients involve primarily the skin and joints. The most frequent immunologic abnormalities include mixed cryoglobulins, rheumatoid factor, antinuclear, anticardiolipin, and antithyroglobulin antibodies. Cryoglobulin positivity is associated with systemic vasculitis and rheumatoid factor and HIV positivity. HIV coinfection is associated with arthralgia or myalgia, anticardiolipin antibodies, and thrombocytopenia.
引用
收藏
页码:47 / 56
页数:10
相关论文
共 92 条
[1]   HEPATITIS-C VIRUS-INFECTION IN TYPE-II MIXED CRYOGLOBULINEMIA [J].
ABEL, G ;
ZHANG, QX ;
AGNELLO, V .
ARTHRITIS AND RHEUMATISM, 1993, 36 (10) :1341-1349
[2]   NON-ORGAN SPECIFIC AUTOANTIBODIES ASSOCIATED WITH CHRONIC C-VIRUS HEPATITIS [J].
ABUAF, N ;
LUNEL, F ;
GIRAL, P ;
BOROTTO, E ;
LAPERCHE, S ;
POUPON, R ;
OPOLON, P ;
HURAUX, JM ;
HOMBERG, JC .
JOURNAL OF HEPATOLOGY, 1993, 18 (03) :359-364
[3]   HCV AND SJOGRENS-SYNDROME [J].
ACETI, A ;
TALIANI, G ;
SORICE, M ;
AMENDOLEA, MA .
LANCET, 1992, 339 (8806) :1425-1426
[4]   A ROLE FOR HEPATITIS-C VIRUS-INFECTION IN TYPE-II CRYOGLOBULINEMIA [J].
AGNELLO, V ;
CHUNG, RT ;
KAPLAN, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1490-1495
[5]   HEPATITIS-C VIRUS AND SJOGRENS-SYNDROME [J].
ALMASIO, P ;
PROVENZANO, G ;
SCIMEMI, M ;
CASCIO, G ;
CRAXI, A ;
PAGLIARO, L .
LANCET, 1992, 339 (8799) :989-990
[6]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[7]  
BEDOSSA P, 1994, HEPATOLOGY, V20, P15
[8]  
BOROTTO E, 1994, GASTROEN CLIN BIOL, V18, P813
[9]  
BORQUE L, 1991, CLIN EXP RHEUMATOL, V9, P617
[10]   Xerostomia and hepatitis C virus: A Sjogren like syndrome. [J].
Boscagli, A ;
Hatron, PY ;
CanvaDelcambre, V ;
Hachulla, E ;
Janin, A ;
Paris, C ;
Devulder, B .
REVUE DE MEDECINE INTERNE, 1996, 17 (05) :375-380